Skip to main content
BSF ENTERPRISE PLC logo

BSF ENTERPRISE PLC — Investor Relations & Filings

Ticker · BSFA ISIN · GB00BHNBDQ51 LEI · 2138007PJT69H8FYLC06 IL Professional, scientific and technical activities
Open in API
Filings indexed 171 across all filing types
Latest filing 2024-01-31 Annual Report
Country GB United Kingdom
Listing IL BSFA

About BSF ENTERPRISE PLC

https://bsfenterprise.com/

BSF Enterprise PLC is a biotechnology company that develops and commercializes cell-based, tissue-engineered solutions. The company focuses on creating innovative materials and products for various applications, including cultivated meat, lab-grown leather, and technologies for corneal repair. The core business model involves acquiring and advancing proprietary technologies in cellular agriculture and regenerative medicine with the objective of licensing its intellectual property.

Recent filings

Filing Released Lang Actions
Full Year Results
Annual Report Classification · 100% confidence The document is titled 'Annual Report and Consolidated Financial Statements for the year ended 30 September 2023' for BSF Enterprise PLC. It contains comprehensive financial statements, auditor's reports, and management commentary, which aligns perfectly with the definition of an Annual Report (10-K). FY 2023
2024-01-31 English
FOODTECH Joint Venture with CellRev
M&A Activity Classification · 99% confidence The document begins with 'RNS Number' and is dated '08 December 2023'. It announces a significant business development: a Joint Venture between BSF Enterprise PLC and CellulaRevolution Ltd to form 'Cultivated Meat Technologies Limited (CMT)'. The text concludes with contact information and a footer explicitly stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure and content strongly indicate a general regulatory announcement disseminated via the London Stock Exchange's Regulatory News Service (RNS). Since the announcement is about a strategic business development (a joint venture) and not a specific financial report (like 10-K, ER, or IR), the most appropriate classification is the general regulatory filing category.
2023-12-08 English
Standard form for notification of major holdings
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 2686V' and contains the standard form 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification. The content details the person subject to notification (Myles McNulty and family interests), the date the threshold was crossed (28/11/2023), and the resulting percentage of voting rights (3.19%). This aligns perfectly with the 'Major Shareholding Notification' category (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general 'RNS' fallback.
2023-11-30 English
3D Bio-Tissues Product Partnership Progress
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated '24 November 2023'. It provides operational updates regarding product partnerships (Etsyl™), grant awards (EIT Grant for City-Mix™), and personnel changes. The text concludes with standard boilerplate information referencing RNS, the London Stock Exchange, and the Financial Conduct Authority (FCA). This structure is characteristic of a general regulatory news service announcement, which is the definition of RNS (Regulatory Filings). It is not a comprehensive financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A). Since it is a general operational update disseminated via the RNS system, RNS is the most appropriate classification.
2023-11-24 English
New Cornea Company & Investor Update
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated '26 October 2023'. It provides a strategic update titled 'New Cornea Company & Investor Update', announcing the formation of a new subsidiary (Kerato Limited), management appointments, funding status, and recent investor activities. The presence of the RNS header and the nature of the announcement (corporate update, strategic news, management change) strongly indicate this is a general regulatory disclosure disseminated via the London Stock Exchange's news service. Since it is a specific corporate announcement that doesn't fit into the more specialized categories like Director's Dealing (DIRS), Earnings Release (ER), or Capital Change (SHA), the most appropriate classification is the general regulatory filing category, RNS.
2023-10-26 English
Participation in The ThinkEquity Conference
Regulatory Filings Classification · 99% confidence The document is identified by the RNS Number header and contains an announcement dated October 9, 2023. The content explicitly states that the company, BSF Enterprise PLC, will be 'participating in The ThinkEquity Conference' and details the presentation time and location. This is a corporate event announcement intended for investors, not a formal financial report (like 10-K or IR) or a transcript of a call. Since it is a general corporate update distributed via RNS, and it doesn't fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), it falls best under the general Regulatory Filings category (RNS) as a standard market communication, although it is essentially an Investor Relations update. Given the options, RNS is the most appropriate catch-all for this type of non-standard, timely announcement distributed through the regulatory feed.
2023-10-09 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.